Načítá se...
Basiliximab Induction with Delayed Calcineurin Inhibitors for High-Risk Lung Transplant Candidates
PURPOSE: Calcineurin inhibitor (CNI) use has improved lung transplantation outcomes. However, significant perioperative complications in patients receiving CNI can deteriorate the early course of lung transplantation. To date, there is no consensus regarding the optimal agent for the induction regim...
Uloženo v:
| Vydáno v: | Yonsei Med J |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Yonsei University College of Medicine
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7859690/ https://ncbi.nlm.nih.gov/pubmed/33527796 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2021.62.2.164 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|